Glycyrrhetinic acid alleviates hepatic inflammation injury in viral hepatitis disease via a HMGB1-TLR4 signaling pathway.

Int Immunopharmacol · 2020 · PMC7205693 · PMID 32416454

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

As the marker of hepatotoxicity, ALT exhibited a decreasing trend until the level of 530 IU/ml ( Fig. 3 C).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.